CZ-backed YZi Labs escalates fight over CEA’s ‘poison pill’ and BNB treasury strategy
YZi Labs is challenging CEA Industries’ newly adopted poison pill and bylaw changes, accusing the board of entrenchment and misrepresenting its commitment to a BNB treasury.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
YZi Labs is challenging CEA Industries’ newly adopted poison pill and bylaw changes, accusing the board of entrenchment and misrepresenting its commitment to a BNB treasury.
Why this matters
BNB is showing up inside the Institutional Adoption theme, so this story is worth tracking for follow-through rather than treating it as a one-off headline.
Original source
Read on CointelegraphRelated market context
MetaMask Gets Left Behind? Consensys Launches New Institutional Settlement Network
MetaMask is facing fresh questions about its future after Consensys launched a new institutional settlement network targeting bank...
Strategy Adds 811 Bitcoin and Repurchases $208.2M of STRC Shares
TL;DR: Strategy announced on November 2 that it had acquired another 811 Bitcoin for roughly $65.5 million and repurchased approxi...
Strategy’s MSTR daily trading volume surpasses Boeing’s
The surge in Strategy's trading volume highlights the growing influence of Bitcoin sentiment on market dynamics, challenging tradi...
Aave Labs, Kamino and Veda submit DeFi lending legal framework to the SEC
The submission could pave the way for clearer DeFi regulations, potentially boosting market liquidity and attracting institutional...
NEAR Blockchain Holders Vote to Trim Max Issuance to 1.6%, Pending Validator Adoption
NEAR Protocol‘s onchain governance body, the House of Stake, has voted to lower the network’s yearly issuance ceiling from 2.5% to...
Capital Group’s Fundamental Investors fund adds approximately $20 million in Strategy shares
Capital Group's increased stake in Strategy highlights institutional confidence in crypto-linked equities, impacting market percep...